Stage IIIB Prostate Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for AZD-8186 (DB15029)

IndicationStatusPhase
DBCOND0109671 (Stage IIIB Prostate Cancer AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03218826PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryTreatment